• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Fueling Cognitive Health through Nutrition & Supplementation

    2020 State of the Industry: High Expectations

    2020 International Buyers' Guide

    Clean Label Questions: Anything But ‘Short and Sweet’

    Key Trends in Functional Foods & Beverages for 2020
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    DCC Acquires Contract Manufacturer Ion Laboratories

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Mintel Identifies Global Food and Drink Trends Over Next 10 Years
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Cannabinoid Testing & Quality: Michael Poleselli on the VivAssure Standard

    Mood33 to Introduce Hemp-Infused Herbal Teas Featuring Evo Hemp

    Elixinol Gains USDA Organic Certification for CBD Tincture
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    DCC Acquires Contract Manufacturer Ion Laboratories

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Mintel Identifies Global Food and Drink Trends Over Next 10 Years

    Cannabinoid Testing & Quality: Michael Poleselli on the VivAssure Standard
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    Obesity and Gum Disease May Have Common Connection: Inflammation

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic

    Clinical Trial Confirms Joint Health Benefits of NEM Brand Eggshell Membrane in 7 Days
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Barrington Nutritionals

    Sabinsa Corporation

    Shanghai Freemen

    ExcelVite Sdn. Bhd.

    Aiya America (Matcha by Aiya)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    PLT Health Solutions

    Barrington Nutritionals

    MitoCarn (Alfasigma)

    Shanghai Freemen

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Is Google’s AdSense System Biased Against Dietary Supplements?

    The company lumps drugs and supplements into a single ad category, creating an unwitting bias in favor of pharma.

    Is Google’s AdSense System Biased Against Dietary Supplements?
    Related CONTENT
    • Taking the Mystery Out of Medical Foods
    • How to Assess Risk in the Current Dietary Supplement Industry
    • 24 Years After DSHEA, Industry Still Lacks ODI Clarity
    • The Healthy Aging Imperative
    • An Interview with John Siefert of STYR Labs
    By Erik Goldman, Holistic Primary Care10.01.18
    Over the last 18 months, we at Holistic Primary Care have been deeply involved in the process of expanding our online presence, and engaging new audiences with our medical content.

    Through that process, we’ve had to learn a bit about the arcane arts of search engine optimization and keyword-based online advertising. And recently, as we began using the Google AdSense platform to bring new advertising streams onto our site, we discovered something deeply troubling: the Google AdSense platform does not distinguish between pharmaceutical and dietary supplement ads.

    The platform enables online publishers like HPC, and others in the field, to filter the ads that Google posts to our website by selecting from a list of categories which Google provides. We, and other publishers, try to select ad categories that are most related to our website’s content.

    In the realm of healthcare, Google’s ad category list includes a single header for “Drugs and Supplements.” It basically lumps these two industries—and two types of ads—together into a single group.

    This is extremely problematic for us as publishers of content related to holistic medicine, and also for you as a marketer of non-pharmaceutical products.

    Why? Because by grouping supplements and pharmaceuticals into a single category, Google is unwittingly—and we believe unintentionally—creating a bias that favors pharmaceutical ads.
    We discovered this problem earlier this summer, when we began to deploy the AdSense system on our site. Within weeks, we began to see pharma ads—for cancer drugs, psychiatric drugs, immunomodulatory drugs—popping up on the site. Most were only vaguely relevant to the editorial content next to which they appeared.

    Fortunately, we work with a sharp IT partner, who has the knowledge and skills to dig deeply into the analytics, and the workings of Google’s algorithms.

    He and his team figured out that because Google lumps “Supplements” and “Drugs” together, the drug companies (or shell websites created by them) are able to buy up keywords relevant to holistic medicine (and, to be fair, nearly all healthcare related topics) and stack the odds that their ads will show up when readers seek information on healthcare alternatives.

    For example, an online reader searching Google for articles on “probiotics after antibiotics” will likely find her way to HPC’s article on this topic. But the ad next to that article could be an ad for a Proton Pump Inhibitor, or an anti-inflammatory drug for Crohn’s Disease. We have seen this happen many times on our site. 

    Google’s system does allow publishers and website hosts to block individual ads. But this can be very time-consuming; it obliges us to monitor our content and our ads constantly, and then spend time and energy tracking down the sources of each undesired ad and applying the appropriate coding to block each one individually.

    This can quickly become a game of whack-a-mole, because the pharmaceutical companies can easily create new websites on domain names that seem totally unrelated and independent, through which they can then buy advertising keywords and deploy the parent company’s ads.

    Industry Impact
    In addition to being a hassle for us as publishers, we believe Google’s current setup has significant negative impact for any company that advertises dietary supplements or natural products through AdSense.

    Putting it most simply, the drug companies can outspend you, and Google’s system is set up in such a way that drug ads are likely to show up where your ads ought to be appearing.
    The grouping of pharmaceutical and dietary supplement ads into a single AdSense category is problematic for several reasons:
    1. Websites wishing to be open to ads from supplement or natural product companies must by default be open to pharma ads. Short of individually blocking each unwanted ad that pops up on our site, we as website hosts have no easy way to ensure that only ads from supplement and nutrition companies will appear on our website. 
    2. The current categorization creates inherent bias in favor of pharma. Google’s categorization schema gives an unfair competitive advantage to pharma companies, while disfavoring supplement advertisers. Drug companies have vastly bigger marketing budgets and greater online strategic capabilities. They can easily outspend supplement companies, ensuring their ads are linked to keywords representing holistic, natural, and functional medicine. Because of this, drug ads frequently pop up next to content about non-pharma healthcare alternatives.
    3. It is unfair to online readers. Under Google’s current system, people seeking online information about holistic healthcare and functional medicine are routinely exposed to ads for the very types of products for which they are seeking alternatives. AdSense placement of drug ads on sites featuring content about holistic, integrative, or functional medicine means that the ads and editorial content are mismatched from a reader’s perspective.
    4. Google’s lack of distinction between drug and supplement ads runs counter to intent of federal regulations. The Dietary Supplement Health and Education Act (DSHEA) makes it clear that supplements and prescription drugs are two entirely distinct product categories that must not be mixed or misconstrued. Over the last 24 years since passage of DSHEA, FDA has unequivocally reinforced that position. In saying this, we are not implying that AdSense is in violation of the law; we’ve spoken with industry attorneys who informed us that Google is not bound by DSHEA, and that its ad categorization scheme is not illegal. But the system’s combining of drug and supplement ads is definitely not in alignment with the intent of DSHEA or the FDA’s enforcement of it.
    5. It is unfair to online publishers using Google’s AdSense platform. Websites wishing to display supplement ads but not pharma ads must expend time and human resources monitoring, tracking, and blocking the unwanted drug ads individually, because they cannot be blocked as a category. The combined pharma-supplement category also makes it difficult for publishers to determine what percentage of total AdSense revenue comes from Pharma vs Supplement ads, unless they go deeply into the analytics and track every single AdSense placement. This is time and labor-intensive.
    Taking Action
    As a publishing company with a deep commitment to natural nutrition-based medicine and freedom for healthcare alternatives, we at Holistic Primary Care are deeply concerned about this issue.

    We are working to find the appropriate person within Google’s administration that has authority over the company’s ad categorization schema. We plan to contact this individual and urge Google to make a simple change to the AdSense platform that would create two distinct and non-overlapping categories, one for Pharmaceuticals, and a separate one for Dietary Supplements.

    Such a change would:
    • Serve online health information-seekers by creating greater alignment between the types of content they are seeking and the types of ads that appear in connection with said content;
    • Serve online health information publishers by making it easier for them to monitor, to distinguish between, and to make informed choices about the types of ads displayed on their websites;
    • Eliminate inherent and probably unintentional bias that favors the drug industry and disfavors supplement industry advertisers;
    • Serve Google itself by bringing AdSense into alignment with a federal law that makes a clear distinction between pharmaceuticals and dietary supplements; and by creating two separate revenue-generating categories out of the existing single category.
    • Engage companies and websites not currently using AdSense because they do not like the current framework for ad categorization.
    If you share our concern about this problem, please be in touch. You can reach me via e-mail at: Erik@holisticprimarycare.net. I believe that if we, as an industry, can come together with a unified voice we can convince Google to reconsider and revise its existing ad categorization structure. It is certainly worth a shot!


    Erik Goldman
    Holistic Primary Care

    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide. He is also co-producer of the Practitioner Channel Forum, the nation’s leading conference focused on opportunities and challenges in the practitioner segment of the dietary supplement industry. 
    Related Searches
    • Health
    • fda
    • Dietary Supplement
    • DSHEA
    Related Knowledge Center
    • Dietary Supplements
    • Healthcare Trends
    • Regulations
    Suggested For You
    Getting Ahead of the Curve: Natural OTCs Getting Ahead of the Curve: Natural OTCs
    Harvard Researcher Questions Probiotic Benefits Harvard Researcher Questions Probiotic Benefits
    Court Orders Injunction Against Companies Selling Products with Undisclosed Drugs Court Orders Injunction Against Companies Selling Products with Undisclosed Drugs
    Foundations for Formulating Skin Care Products Foundations for Formulating Skin Care Products
    Deerland Enzymes and Probiotics Obtains FSSC 22000 Certification Deerland Enzymes and Probiotics Obtains FSSC 22000 Certification
    CRN Voluntary Guidelines Reinforce Industry Commitment to Consumer Safety CRN Voluntary Guidelines Reinforce Industry Commitment to Consumer Safety
    Confusion Over Cannabis & The Fate of CBD Confusion Over Cannabis & The Fate of CBD
    Tips & Tricks for Walking the Insurance Application Minefield Tips & Tricks for Walking the Insurance Application Minefield
    2018 Branded Ingredient Showcase 2018 Branded Ingredient Showcase
    Safeguarding Your Intellectual Property for Nutraceuticals Safeguarding Your Intellectual Property for Nutraceuticals
    Aging Consumers & New Technology Fuel the Radically Changing Healthcare Landscape Aging Consumers & New Technology Fuel the Radically Changing Healthcare Landscape
    The Healthy Aging Imperative The Healthy Aging Imperative
    An Interview with John Siefert of STYR Labs An Interview with John Siefert of STYR Labs
    24 Years After DSHEA, Industry Still Lacks ODI Clarity 24 Years After DSHEA, Industry Still Lacks ODI Clarity
    Taking the Mystery Out of Medical Foods Taking the Mystery Out of Medical Foods

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Quality & Safety | Regulations | Testing
      Developing Scientific Support for Product Claims

      Developing Scientific Support for Product Claims

      Generally accepted scientific principles should be used to determine the quality of studies used as evidence to substantiate a claim.
      By Greg Stephens, Windrose Partners & Sanford W. Bigelow, PhD, DABT, Vanguard Global Associates LLC 11.05.19

    • Dietary Supplements | Herbs & Botanicals | Natural/Organic | Quality & Safety | Regulations | Testing
      The Wild West Sells More than Just CBD

      The Wild West Sells More than Just CBD

      Self-determined GRAS is not a cure-all for NDINs, so be responsible and conduct the necessary safety and toxicology work.
      By Todd Harrison, Venable 11.05.19

    • Regulations | World Markets
      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Maximum intake amounts of many micronutrients are still not regulated throughout the EU.
      By Joerg Gruenwald, analyze & realize ag 11.05.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Research | Testing
      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 11.05.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Quality & Safety | Regulations
      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.
      By Erik Goldman, Holistic Primary Care 10.07.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      The insurance marketplace for hemp growers and CBD manufacturers will continue to expand.
      By Sheldon Baker, Baker Dillon Group LLC 10.07.19


    • Antioxidants | Dietary Supplements | Digestive Health | Herbs & Botanicals | Minerals | Research | Vitamins
      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      A remedy for many ailments in Ayurvedic medicine, science continues to uncover new uses for this common flavoring agent.
      By Dilip Ghosh, PhD, FACN, nutriConnect 10.07.19

    • Dietary Supplements | Healthcare Trends | Quality & Safety | Regulations
      Clinical Nutrition: A New Market Opportunity

      Clinical Nutrition: A New Market Opportunity

      Clearer language and scientific documentation for product benefits could open new doors for nutraceuticals in healthcare settings.
      By Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 09.09.19

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Regulatory Status Update: The Chaos Continues

      CBD Regulatory Status Update: The Chaos Continues

      FDA already has the authority to create a legal pathway for cannabidiol. It just needs the will to implement it.
      By Todd Harrison, Venable 09.09.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Regulations | World Markets
      Regulatory Harmonization in Europe: CBD Case Study

      Regulatory Harmonization in Europe: CBD Case Study

      Despite long-standing efforts, many EU regulatory standards are still out of alignment.
      By Joerg Gruenwald, analyze & realize ag 09.09.19

    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      Mile High Labs: Stephen Mueller & The Mile High Monster

      Mile High Labs: Stephen Mueller & The Mile High Monster

      As chief technology officer and founder, he is the technical visionary of Mile High Labs and is designing/building and operating the future of hemp extraction.
      By Sheldon Baker, Baker Dillon Group LLC 07.03.19

    • Dietary Supplements | Regulations | World Markets
      Australia: Leading Regulation of Complementary Medicines

      Australia: Leading Regulation of Complementary Medicines

      The TGA recently implemented a Compliance Rating Scheme for listed medicines.
      By Dilip Ghosh, PhD, FACN, nutriConnect 07.03.19

    • Dietary Supplements | Regulations
      DSHEA Discussion: Assessing Standards for Scientific Evidence

      DSHEA Discussion: Assessing Standards for Scientific Evidence

      Adjusting the health claims system could encourage more clinical trials and benefit consumers.
      By Todd Harrison, Venable 06.03.19

    • Dietary Supplements | Regulations | World Markets
      Non-Specific Health Claims: Beyond the Letter of the Law

      Non-Specific Health Claims: Beyond the Letter of the Law

      These statements are acceptable as long as they are either accepted generic descriptors or accompanied by a specific health claim.
      By Joerg Gruenwald, analyze & realize ag 06.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      The need for clear and truthful clinical communication should be on the table for discussion as DSHEA goes under review.
      By Erik Goldman, Holistic Primary Care 05.02.19

    Breaking News
    • Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    • OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    • DCC Acquires Contract Manufacturer Ion Laboratories
    • AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption
    • Mintel Identifies Global Food and Drink Trends Over Next 10 Years
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • 2020 International Buyers' Guide
    • 2020 State of the Industry: High Expectations
    • Fueling Cognitive Health through Nutrition & Supplementation
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Bouckaert to Launch New Equipment
    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.